Kongressthemen
The ITOC series of conferences is the premier meeting for education, scientific exchange, and networking within the cancer immunotherapy field. It aims at providing a forum for all professionals working in immunotherapy to discuss early clinical drug development and address the unique challenges of translational research.
The programme will focus on the latest challenges and innovations with a special emphasis on combination therapy, immuno-monitoring and biomarker development.
Lernziele, Trainingsziele
The programme will focus on the latest challenges and innovations with a special emphasis on combination therapy, immuno-monitoring and biomarker development.
Zielpublikum
At this conference, we are in particular addressing preclinical and clinical scientists, clinical investigators, postdoctoral fellows involved in cancer research, regulatory scientists, healthcare professionals and the pharmaceutical industry.
Akkreditierung
UEMS/EACCME
Kongressorganizer (PCO)
Wiener Medizinische Akademie GmbH / Conference Manager
Lokaler Veranstalter
ITOC5 is presented by CDDF in collaboration with SITC
Online registration is available here: http://itoc-conference.eu/itoc5-conference/registration
Frau Catherine Tomek
KategorienImmunologie, Onkologie